Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) could improve patient adherence and simplify treatment ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Never miss an episode of Florida Health Care Insider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback